Alterations of synaptic transmission have been considered a core feature of mental disorders; thus, we examined the role of dopamine D 4 receptors, which is highly implicated in attentiondeficit hyperactivity disorder and schizophrenia, in regulating synaptic functions of prefrontal cortex, a brain region critical for cognitive and emotional processes. We found that D 4 stimulation caused a profound depression or potentiation of AMPA receptormediated excitatory synaptic transmission in prefrontal cortex pyramidal neurons when their activity was elevated or dampened, respectively, which was accompanied by a D 4 -induced decrease or increase of AMPARs at synapses. The dual effects of D 4 on AMPAR trafficking and function was dependent on the D 4 -mediated bidirectional regulation of CaMKII activity via coupling to distinct signaling pathways, which provides a unique mechanism for D 4 receptors to serve as a homeostatic synaptic factor to stabilize cortical excitability. P refrontal cortex (PFC) is a brain region critically involved in the high-level "executive" processes, including working memory, novelty seeking, and emotional control (1, 2). PFC neurons are highly innervated by dopaminergic projections (3). Aberrant dopaminergic actions have been implicated in PFC abnormalities associated with mental disorders, such as attention deficithyperactivity disorder (ADHD) and schizophrenia (4, 5).
Alterations of synaptic transmission have been considered a core feature of mental disorders; thus, we examined the role of dopamine D 4 receptors, which is highly implicated in attentiondeficit hyperactivity disorder and schizophrenia, in regulating synaptic functions of prefrontal cortex, a brain region critical for cognitive and emotional processes. We found that D 4 stimulation caused a profound depression or potentiation of AMPA receptormediated excitatory synaptic transmission in prefrontal cortex pyramidal neurons when their activity was elevated or dampened, respectively, which was accompanied by a D 4 -induced decrease or increase of AMPARs at synapses. The dual effects of D 4 on AMPAR trafficking and function was dependent on the D 4 -mediated bidirectional regulation of CaMKII activity via coupling to distinct signaling pathways, which provides a unique mechanism for D 4 receptors to serve as a homeostatic synaptic factor to stabilize cortical excitability. P refrontal cortex (PFC) is a brain region critically involved in the high-level "executive" processes, including working memory, novelty seeking, and emotional control (1, 2) . PFC neurons are highly innervated by dopaminergic projections (3) . Aberrant dopaminergic actions have been implicated in PFC abnormalities associated with mental disorders, such as attention deficithyperactivity disorder (ADHD) and schizophrenia (4, 5) .
The expression of D 4 receptors is largely restricted to PFC neurons (6) . Multiple studies have indicated that ADHD is associated with a D 4 gene polymorphism that weakens D 4 receptor function (7) (8) (9) (10) . Preclinical studies suggest that D 4 plays a pivotal role in the expression of juvenile hyperactivity and impulsive behaviors associated with ADHD (11) . Moreover, elevated D 4 ligand-binding sites and increased D 4 mRNA levels are found in forebrain tissue of schizophrenics (12) . The uniquely effective antipsychotic drug used in schizophrenia treatment, clozapine, has a high affinity to D 4 receptors (13, 14) . In addition, D 4 receptor antagonists alleviate stress-induced working-memory problems in monkeys (15) and ameliorate cognitive deficits caused by the psychotomimetic drug phencyclidine (16) . Mice lacking D 4 receptors exhibit supersensitivity to psychomotor stimulants, reduced exploration of novel stimuli, and cortical hyperexcitability (17) (18) (19) . These lines of evidence strongly support that D 4 receptors are critically involved in PFC functions both under the normal condition and in many neuropsychiatric disorders (20, 21) .
Behavioral studies have found that D 4 receptors exert bidirectional effects on PFC working memory according to the baseline performance (22) . To advance our understanding of how this enigmatic dopamine receptor regulates PFC functions, we need to identify its molecular target in PFC neurons. Our previous studies (23, 24) have shown that D 4 receptors exert a complex and dynamic regulation of CaMKII, a multifunctional enzyme that plays a central role in regulating several key postsynaptic targets required for learning and memory (25) . One prominent target of CaMKII is the AMPA receptor (26, 27) , which directly controls the excitatory output of PFC.
In this study, we have examined the impact of D 4 receptors on AMPAR-mediated synaptic transmission in PFC pyramidal neurons. We found that D 4 receptors exerted an activity-dependent bidirectional regulation of AMPA responses, which involved CaMKII-regulated AMPAR trafficking at synapses. This novel regulation endows D 4 receptors with the ability to dynamically alter glutamatergic transmission according to the activity levels of PFC pyramidal neurons. The homeostatic control of synaptic strength by D 4 receptors could act to stabilize the activity of PFC circuits.
Results
Activity of PFC Pyramidal Neurons Is Dynamically Regulated. To test whether cortical neuronal activity can be manipulated rapidly, we pretreated rat (3-4 wk) PFC slices with bicuculline (Bic, 10 μM, 2 h) to block inhibitory transmission or with TTX (0.5 μM, 2 h) to suppress neuronal firing, similar to the paradigms used by others (28, 29) . Bic or TTX was washed off for 0.5 to 2 h before recording. As shown in Fig. 1 A-C, following Bic or TTX pretreatment, neuronal excitability was significantly elevated or dampened, respectively, as indicated by the significantly increased or decreased spike frequency. We also incubated PFC slices with a low (1 mM) Mg 2+ artificial cerebrospinal fluid (ACSF) (2 h) (30) or the NMDAR blocker 2-amino-5-phosphonovaleric acid (APV, 25 μM, 2 h), as another paradigm to elevate or dampen neuronal activity, respectively. Consistently, we found that the low Mg 2+ ACSF increased, and APV pretreatment decreased, neuronal excitability significantly ( Fig. 1 A, C, and D) . The basic properties, including resting potential, input resistance, and action potential half-width, were not significantly altered by these drug treatments, but the rheobase (the smallest current injection that elicited a single spike) was significantly decreased by Bic or low Mg 2+ ACSF, and increased by TTX or APV (Table S1) .
Next, we investigated whether the altered neuronal activity by these manipulations may be caused by the changes in synaptic strength. As shown in Fig. 1 D and E, the evoked excitatory postsynaptic currents (eEPSC) was significantly increased by Bic pretreatment, and decreased by TTX pretreatment (nontreated: 103.3 ± 6.5 pA, n = 16; +Bic: 151.0 ± 7.9 pA, n = 14; +TTX: 49.4 ± 5.4 pA, n = 13; P < 0.01, ANOVA), but the evoked inhibitory postsynaptic currents (eIPSC) was unchanged (nontreated: 218.8 ± 19.1 pA, n = 11; +Bic: 248.3 ± 38.6 pA, n = 8; +TTX: 263.1 ± 32.3 pA, n = 9; P > 0.05, ANOVA). Low Mg 2+ ACSF also increased, but APV pretreatment decreased, eEPSC (Fig. 1D) . Moreover, in cultured PFC pyramidal neurons (days in vitro [24] [25] [26] [27] [28] , the miniature EPSC (mEPSC) amplitude and frequency were significantly increased by Bic-pretreatment, and significantly decreased by TTX-pretreatment (Fig. 1 F and G) (nontreated: 32.5 ± 1.5 pA, 5.7 ± 0.5 Hz, n = 10; +Bic: 39.2 ± 1.7 pA, 7.9 ± 0.5 Hz, n = 13; +TTX: 20.6 ± 1.1 pA, 3.5 ± 0.2 Hz, n = 10; P < 0.01, ANOVA). These data suggest that PFC neuronal excitability and synaptic activity is up-regulated by a short treatment with Bic and down-regulated by a short treatment with TTX. Moreover, these changes were maintained in a prolonged manner (Fig. S1 ). To study the potential impact of D 4 receptors on glutamatergic transmission, we examined the effect of D 4 R agonist PD168077 on AMPAR-EPSC in PFC pyramidal neurons. Neurons were held at −70 mV, and EPSC was evoked by stimulating neighboring pyramidal neurons. The recorded eEPSC is mediated by AMPA receptors, as it was almost completely blocked by the selective AMPAR antagonist NBQX (10 μM), but was not altered by Bic (10 μM) or APV (100 μM) (Fig. S2) . Application of PD168077 (40 μM) caused a significant reduction of AMPAR-EPSC ( Fig. 2 A and C) (22 ± 2.2%, n = 8). In contrast, PD168077 had almost no effect in striatal medium spiny neurons (5.0 ± 3.2%, n = 5), consistent with the abundant expression of D 4 receptors in PFC but not in striatum. Furthermore, the D 4 R antagonist L-741742 (20 μM) blocked the effect of PD168077 (Fig. S3A ) (4.4 ± 1.5%, n = 5), suggesting the mediation by D 4 receptors. The "antagonist chasing" experiment, in which L-741742 was applied after the D 4 effect had been established, indicated that the PD168077 (40 μM)-induced decrease of EPSC in PFC slices failed to return to the baseline level after 20 min of "antagonist chasing" (Fig. S3B ) (27.1 ± 1.3%, n = 5), suggesting that D 4 R downstream signaling molecules, but not D 4 R itself, are mediating the long-lasting effects.
We next examined whether the D 4 regulation of AMPAR-EPSC in PFC pyramidal neurons is influenced by neuronal activity. In Bic-pretreated slices, the reducing effect of PD168077 (40 μM) on AMPAR-EPSC was significantly augmented ( PD168077 caused a profound enhancement of AMPAR-EPSC ( Fig. 2 D and E) (55.6 ± 3.3%, n = 24). Both effects were persistent and sustained for 30 min after removal of PD168077. The dual effects of PD168077 were not because of washing off Bic or TTX, as a stable current was recorded in control cells when no PD168077 was applied ( Fig. 2 B and D) . Briefer Bic pretreatment failed to significantly augment the reducing effect of PD168077 on AMPAR-EPSC (10 min: 19.5 ± 2.8%, n = 8; 1 h: 21.4 ± 6.7%, n = 5), but briefer TTX pretreatment led PD168077 to cause no or small enhancement of AMPAR-EPSC (10 min: 6.7 ± 1.1%, n = 6; 1 h: 23.0 ± 3.3%, n = 6). This finding suggests that a prolonged (2 h) Bic or TTX pretreatment of PFC slices is necessary to enable D 4 to cause a strong depression or potentiation of AMPAR synaptic responses. PD168077 did not alter the paired-pulse ratio of AMPAR-EPSC, a readout that is affected by presynaptic transmitter release ( Fig. S3C ) (nontreated: 3.1 ± 1.2% change, n = 8; Bic-pretreated: 2.5 ± 0.6% change, n = 8), suggesting that the D 4 regulation of AMPAR-EPSC is through modifying postsynaptic AMPA receptors. Dose-response data indicate that the reducing or enhancing effect of PD168077 (1-100 μM) in Bic-or TTX-pretreated neurons reached the saturating level at 40 μM; thus, 40 μM of PD168077 was used in most of our experiments to ensure D 4 receptors are fully activated in PFC pyramidal neurons. The dual effects of PD168077 (40 μM) were blocked by the D 4 R antagonist L-741,742 (20 μM) [Bic-pretreated: 9.4 ± 2.5% reduction, n = 5 (Fig. 2C) ; TTX-pretreated: 8.0 ± 2.8% enhancement, n = 5 ( Fig. 2E) ].
When neuronal activity was elevated by the low Mg 2+ ACSF, PD168077 induced a much bigger reduction of AMPAR-EPSC (46 ± 3.3%, n = 8) (Fig. 2C) , and failed to cause more reduction in PFC slices with combined pretreatment of Bic plus low Mg 2+ ACSF (48.1 ± 4.6%, n = 5), suggesting that the Bic and low Mg 2+ effects occlude one another. In APV-pretreated slices, PD168077 caused an enhancement of AMPAR-EPSC (52 ± 2.8%, n = 9) (Fig. 2E) , and failed to cause more enhancement in PFC slices with combined pretreatment of TTX plus APV (50.1 ± 3.9%, n = 9) (Fig. 2E) , suggesting that the TTX and APV effects occlude one another.
To further prove that the dual effects of PD168077 are specifically mediated by D 4 receptors, we examined D 4 knockout mice (17) . PD168077 lost the capability to decrease AMPAR-EPSC in PFC pyramidal neurons (Bic-pretreated) from D 4 knockout mice (WT: 47.9 ± 3.8%, n = 5; KO: 3.2 ± 1.9%, n = 7) ( Fig. 2F and Fig. S4B ), as well as in nontreated D 4 −/− neurons (WT: 24.6 ± 2.1%, n = 5; KO: 2.2 ± 1.4%, n = 6) ( Fig. 2F and  Fig. S4A ). PD168077 also lost the capability to increase AMPAR-EPSC in PFC pyramidal neurons (TTX-pretreated) from D 4 knockout mice (WT: 25.1 ± 4.6%, n = 5; KO: 2.7 ± 1.6%, n = 5) (Fig. 2F and Fig. S4C ). Taken together, these findings show that D 4 activation induces a profound depression of AMPAR transmission in PFC at the high-activity state, and a profound potentiation of AMPAR transmission in PFC at the low-activity state.
D 4 -Induced Bidirectional Regulation of AMPAR-Mediated Synaptic
Transmission Is Receptor-, Cell Type-, and Target-Specific. To determine whether endogenous activation of D 4 receptors also dynamically regulates AMPARs, we applied the specific dopamine transporter inhibitor GBR-12909 (10 μM) to block the reuptake of dopamine. The D 2/3 antagonist sulpiride (5 μM) and D 1/5 antagonist SCH23390 (10 μM) were coapplied to block the activation of non-D 4 dopamine receptors. As shown in Fig. S5 , GBR-12909 induced a small reduction of AMPAR-EPSC in nontreated neurons (25.5 ± 3.3%, n = 8), a significantly bigger reduction in Bicpretreated neurons (42.1 ± 3.7%, n = 9), and a robust increase in TTX-pretreated neurons (47.6 ± 4.2%, n = 10). All these effects were largely blocked by the D 4 R antagonist L-741,742. Application of sulpiride plus SCH23390 did not affect basal AMPAR-EPSC, which suggests that activation of D 4 receptors by endogenous dopamine induces an activity-dependent bi-
The dopamine receptor most close to D 4 is D 2 . Application of the D 2 R agonist quinpirole (20 μM) reversibly reduced AMPAR-EPSC (32.3 ± 2.9%, n = 4) (Fig. S6 A and B) in PFC pyramidal neurons. However, this effect was not altered by pretreatment with Bic (34.0 ± 2.3%, n = 4) or TTX (33.3 ± 1.7%, n = 4). This finding suggests that, unlike D 4 , the D 2 regulation of AMPAR-EPSC is independent of PFC neuronal activity. D 4 receptors also regulate AMPAR-EPSC in PFC GABAergic interneurons (31) . However, PD168077 induced a similar reduction of AMPAR-EPSC in this neuronal population, regardless of activity states (Fig. S6 C-F) (53.1 ± 3 .0%, n = 6; Bic-pretreated: 51.3 ± 2.4%, n = 4; TTX-pretreated: 51.2 ± 2.0%, n = 5).
Application of PD168077 also decreased the amplitude of NMDAR-EPSC (41.4 ± 3.0%, n = 5) and GABA A R-IPSC (34.6 ± 2.6%, n = 7) in PFC pyramidal neurons, consistent with our previous reports (32, 33) . However, the effects of PD168077 on NMDAR-EPSC and GABA A R-IPSC were not sensitive to Bic pretreatment (41.0 ± 5.5%, n = 5; 33.0 ± 2.8%, n = 6, respectively), suggesting that, unlike AMPARs, NMDARs and GABA A Rs are down-regulated by D 4 signaling independent of neuronal activity.
To test whether the dual regulation of AMPAR-EPSC by D 4 receptors is a result of the indirect impact of D 4 on GABA A Rs or NMDARs, we also examined the effect of PD168077 on AMPAR-EPSC in PFC slices when Bic and APV were bath applied throughout the recording. As shown in Fig. S7, D 4 still caused a prominent reduction of the pharmacologically isolated AMPAR-EPSC in Bic-pretreated neurons (48 ± 2.7%, n = 8), and a marked increase of AMPAR-EPSC in TTX-pretreated neurons (55.6 ± 7.5%, n = 8). This finding suggests that D 4 regulates AMPAR responses via a mechanism independent of GABA A Rs or NMDARs. To test whether the change in AMPAR trafficking is involved in D 4 regulation of synaptic transmission at different activity states, we carried out a quantitative immunostaining assay. Synaptic GluA1 or GluA2/3 clusters were indicated by those colocalized with the synaptic marker PSD-95 or Synaptophysin. As shown in Fig. 3 A and B, PD168077 (40 μM, 10 min) caused a small reduction of synaptic GluA1 (colocalized with PSD-95) and synaptic GluA2/3 (colocalized with Synaptophysin) cluster density in untreated PFC pyramidal neurons. In Bic (10 μM, 2 h)-pretreated neurons, synaptic GluA1 and synaptic GluA2/3 clusters were significantly increased, and the reducing effect of PD168077 on both became more prominent. On the other hand, in TTX (0.5 μM, 2 h)-pretreated PFC cultures, synaptic GluA1 and synaptic GluA2/3 clusters were significantly decreased, and an enhancing effect was found with D 4 activation on synaptic GluA1, but not on synaptic GluA2/3. The cluster intensity of total GluA1, total GluA2/3, PSD-95 or Synaptophysin was not changed by Bic-or TTX-pretreatment or PD168077 application. Surface biotinylation assay (34) also demonstrated that PD168077 caused a marked reduction of surface GluA1 and GluA2 expression in PFC slices pretreated with Bic (Fig. 3C) . On the other hand, in PFC slices pretreated with TTX, PD168077 significantly increased the level of surface GluA1, but not surface GluA2 (Fig. 3D) .
Next, we performed electrophysiological studies to confirm that D 4 receptors differentially affect AMPAR subunits at high or low activity states. It has been found that GluA2-lacking AMPARs have prominent rectification (35) . As shown in Fig. 4A , the rectification index of AMPAR-EPSC was not significantly altered by PD168077 in Bic-pretreated PFC pyramidal neurons (control: 2.3 ± 0.31, PD: 2.0 ± 0.18, n = 7), but was significantly increased by PD168077 in TTX-pretreated neurons (control: 2.6 ± 0.16, PD: 4.5 ± 0.35, n = 8, P < 0.001, ANOVA). Moreover, Naspm (100 μM, a selective blocker of GluA2-lacking AMPARs) produced little effect on basal AMPAR-EPSC (10.9 ± 4.8%, n = 8). However, following PD168077 application, Naspm brought the enhanced AMPAR-EPSC to the baseline in TTX-pretreated neurons (−Naspm: 45.3 ± 4.5% enhancement, n = 9; +Naspm: 10.2 ± 3.4% enhancement, n = 11) (Fig. 4B) . These results suggest that D 4 suppresses synaptic GluA2-containing AMPAR (GluA1/GluA2) at the high-activity state, but facilitates GluA2-lacking AMPAR (GluA1/GluA1) trafficking to the synaptic membrane at the low-activity state.
CaMKII Is Involved in D 4 Regulation of AMPAR Transmission at Different Activity States. We then examined the possible mechanism by which D 4 bidirectionally regulates AMPARs. It has been found that CaMKII can regulate AMPARs by changing their biophysical properties (36) and their synaptic delivery (27) . Our previous studies show that D 4 decreases CaMKII enzymatic activity in PFC at the high-activity state (23) , and promotes the activation and synaptic translocation of CaMKII in PFC at the low-activity state (23, 24 ). Thus, we tested the role of CaMKII in D 4 regulation of AMPAR transmission. First, we tested the level of active CaMKII (Thr 286 -phosphorylated) in slices pretreated with Bic or TTX. As shown in Fig. S8A , Bic or TTX pretreatment significantly increased or decreased p-CaMKII levels, respectively. After 1 h of washing, pCaMKII returned to the basal level in slices with a short (10 min or 1 h) Bic or TTX pretreatment, but stayed at the elevated or reduced level in slices with 2 h Bic or TTX pretreatment. This finding suggests that prolonged elevation or suppression of neuronal activity is required for maintaining high or low CaMKII activity in a sustained manner.
Next, we tested the effect of D 4 receptors on CaMKII activity in slices with 2 h Bic or TTX pretreatment followed by 1 h washing. As shown in Fig. S8B , PD168077 (40 μM, 10 min) significantly reduced p-CaMKII in Bic-pretreated PFC slices, but significantly increased p-CaMKII in TTX-pretreated slices, confirming that D 4 exerts an activity-dependent, bidirectional regulation of CaMKII enzymatic activity (23) .
To examine whether the D 4 reduction of AMPAR-EPSC at the high-activity state is through suppression of CaMKII, we dialyzed neurons with an EGTA-free internal solution containing purified CaMKII (0.6 μg/mL), calmodulin (30 μg/mL), and CaCl 2 (0.3 mM). The active CaMKII protein itself did not significantly alter the basal EPSC in Bic-pretreated neurons (5.7 ± 2.9%, n = 7), which is likely because of the high level of CaMKII in these cells. The PD168077-induced depression of AMPAR-EPSC in Bic-pretreated neurons was largely blocked by intracellular infusion of the active CaMKII protein (Fig. 5 A and C) (14.6 ± 3.2%, n = 7), but not the heat-inactivated CaMKII protein (48.6 ± 4.0%, n = 6) (Fig. 5C ). On the other hand, dialysis with the CaMKII inhihibitor, AIP peptide (5 μM), caused a significant decrease of basal EPSC in Bic-pretreated neurons (Fig. 5B) (36.2 ± 3 .6%, n = 9) and occluded the reducing effect of subsequently added PD168077 (Fig. 5 B and C) (10.7 ± 2.3%, n = 8), although the scrambled peptide was ineffective.
To examine whether the D 4 enhancement of AMPAR-EPSC at the low-activity state is through stimulation of CaMKII, we dialyzed the AIP peptide to specifically inhibit active CaMKII. AIP (5 μM) itself did not alter the basal EPSC in TTX-pretreated neurons (2.7 ± 2.6%, n = 7), which is likely because of the low level of CaMKII in these cells. The increase of AMPAR-EPSC by PD168077 in TTX-pretreated neurons was blocked in AIPdialyzed neurons (Fig. 5 D and F) (5.4 ± 1.6%, n = 5), but not in neurons loaded with a scrambled peptide (51.8 ± 7.9%, n = 5) (Fig. 5F ). On the other hand, dialysis with the active CaMKII caused a significant increase of basal EPSC in TTX-pretreated neurons (Fig. 5E ) (45.3 ± 5.4%, n = 8) and occluded the enhancing effect of subsequently added PD168077 (Fig. 5 E and F) (5.8 ± 3.5%, n = 6), although the heat-inactivated CaMKII was ineffective. Injecting a high concentration (10 mM) of Ca 2+ chelator BAPTA also blocked the enhancing effect of PD168077 on AMPAR-EPSC (low BAPTA: 53.2 ± 2.0%, n = 5; high BAPTA: 9.4 ± 3.2%, n = 5) (Fig. 5F ). Taken together, these data suggest that D 4 reduces AMPAR-EPSC through suppression of CaMKII at the high-activity state, and D 4 enhances AMPAR-EPSC through stimulation of CaMKII at the low-activity state. Quantitative analysis of synaptic GluA1 (PSD-95 colocalized, yellow puncta) or synaptic GluA2/3 (synaptophysin costained, yellow puncta) clusters along dendrites in different conditions. **P < 0.05; *P < 0.01. (C and D) Immunoblots of surface and total GluA1 and GluA2 subunits and quantification of the surface/total ratio of GluA1 and GluA2 in PFC slices (Bicor TTX-pretreated) without or with PD168077 treatment. *P < 0.01. Consistent with the role of CaMKII in D 4 regulation of AMPAR-EPSC, the enhancing effect of Bic pretreatment (2 h) on mEPSC was prevented by CaMKII inhibitor KN-93 (control: 30.2 ± 1.1 pA, 5.4 ± 0.6 Hz, n = 5; +Bic: 28.0 ± 2.6 pA, 6.0 ± 1.0 Hz, n = 6) ( Fig. S8 C and E) . On the other hand, the reducing effect of TTX pretreatment (2 h) on mEPSC was diminished in neurons infected with the truncated (constitutively active) CaMKII (tCaMKII) Sindbis virus (27) (control: 35.2 ± 1.1 pA, 7.4 ± 0.8 Hz, n = 5; +TTX: 34.6 ± 1.0 pA, 7.6 ± 0.9 Hz, n = 5) (Fig. S8 D and E) , but was not prevented by application of the transcription inhibitor Actinmyocin D (control: 29.0 ± 0.6 pA, 5.8 ± 0.5 Hz, n = 8; +TTX: 20.7 ± 1.2 pA, 2.7 ± 0.6 Hz, n = 10; P < 0.001) (Fig. S8 D and E) . This finding suggests that Bic or TTX pretreatment also converges on CaMKII stimulation or CaMKII suppression to up-or down-regulate synaptic AMPAR responses, respectively.
A B
To complement electrophysiological studies, we also examined the role of CaMKII in D 4 regulation of surface GluA1 expression at different states. To elevate CaMKII activity, PFC slice cultures were infected with tCaMKII Sindbis virus. As shown in Fig.  5 G and H, the reducing effect of PD168077 on surface GluA1 expression was abolished in tCaMKII-infected PFC slices pretreated with Bic (GFP: 0.47 ± 0.1-fold of control, n = 4, P < 0.01, ANOVA; tCaMKII: 1.05 ± 0.06-fold of control, n = 4). On the other hand, in PFC slices pretreated with TTX, the enhancing effect of PD168077 on surface GluA1 expression was blocked by the CaMKII inhibitor KN-93 (20 μM, 1.08 ± 0.07-fold of control, n = 5), but not the inactive analog KN-92 (20 μM, 1.85 ± 0.09-fold of control, n = 5, P < 0.01, ANOVA). This finding further suggests that D 4 regulates AMPAR membrane trafficking dynamically via a CaMKII-dependent mechanism.
Discussion
Intensive research in the activity-dependent bidirectional changes of AMPAR-mediated synaptic transmission, such as long-term potentiation (LTP) induced by high-frequency stimulation and long-term depression (LTD) induced by low-frequency stimulation, has shown that these forms of synaptic plasticity are important for learning and memory (37) . In this study, we demonstrate that a neuromodulator, the D 4 receptor, can uniquely regulate glutamatergic transmission in an activity-dependent bidirectional manner in PFC pyramidal neurons. At the high-activity state, D 4 receptors induce a persistent depression of AMPAR-EPSC, but at the low-activity state, D 4 receptors cause a sustained potentiation of AMPAR-EPSC. Thus, D 4 receptors serve as a homeostatic synaptic factor to stabilize the excitability of PFC pyramidal neurons, which provides a potential mechanism for the cortical hyperexcitability exhibited in D 4 -deficient mice (18) . Given the key role of PFC glutamatergic transmission in working memory (1), our results suggest that D 4 receptors may regulate cognitive processes in a dynamic manner depending on the basal output signal of PFC.
The activity states were set by pretreating PFC slices or cultures with Bic or TTX for 2 h, a paradigm often used to acutely elevate or dampen neuronal activity in vitro, respectively (28, 29) . It has been found that chronic (over a period of days) perturbation of network activity can trigger compensatory changes in synaptic function that contribute to the homeostatic restoration of neuronal activity (38) . However, we found that the neuronal activity level (as indicated by spiking frequency and excitatory synaptic strength) of PFC pyramidal neurons was elevated by Bic pretreatment (2 h), and was reduced by TTX pretreatment (2 h), and these changes could sustain for hours after washout of Bic or TTX, suggesting that homeostatic synaptic scaling has not occurred in mature cortical neurons after the short-term Bic or TTX treatment.
Mounting evidence has demonstrated that the primary basis for synaptic plasticity like LTP or LTD is the trafficking of AMPAR subunits to and from the synapse (39, 40) . Consistent with this notion, the D 4 -induced depression or potentiation of AMPAR-EPSC at different activity states is accompanied by reduced or increased expression of synaptic AMPARs in PFC pyramidal neurons, respectively. In agreement with our results, D 4 activation reduces GluA1 surface expression in hippocampal cultures after chemical LTP induction, and D 4 reduces AMPAR-EPSC amplitudes at potentiated hippocampal synapses (41) . Interestingly, GluA1 and GluA2 subunits are differentially regulated by D 4 receptors. At the high-activity state, D 4 activation removes GluA1/2 heteromeric AMPAR channels from synapses, but at the low-activity state, D 4 activation delivers more GluA1/1 homomeric AMPAR channels to synapses, similar to the trafficking of AMPAR subunits in LTD/LTP induced by electrical stimulation (39) .
CaMKII, a molecular switch that is capable of long-term memory storage (42) , plays a central role in the dual regulation of AMPAR trafficking and function by D 4 receptors. Previously, we have found that D 4 receptors exert a dynamic regulation of CaMKII enzymatic activity and synaptic distribution (23, 24) . At the high-activity state, D 4 couples to the canonical G i pathway to inhibit PKA and cause a decrease in the phosphorylation of inhibitor 1, which leads to disinhibition of protein phosphatase I and reduced activity of CaMKII (23, 32) . At the low-activity state, D 4 utilizes the G q pathway, which leads to activation of phospholipase C, elevation of intracellular Ca 2+ , and ensuing CaMKII activation (23) . The dynamic regulation of CaMKII enables D 4 to regulate CaMKII synaptic substrates in a flexible manner. In this study, we have found that, the D 4 depression of AMPARs at the high-activity state is blocked by activated CaMKII and occluded by CaMKII inhibitors, suggesting its dependence on CaMKII inhibition; however, the D 4 potentiation of AMPARs at the low-activity state is blocked by CaMKII inhibitors and occluded by activated CaMKII, suggesting its dependence on CaMKII activation. This dual regulation of CaMKII activity is unique to D 4 receptors. Activation of D 2 receptors always decreases CaMKII activity, regardless of neuronal activity (23) , which explains the unidirectional regulation of AMPAR-EPSC by D 2 receptors.
In summary, we have revealed a unique action of D 4 receptors in PFC pyramidal neurons: regulation of AMPAR trafficking and function in an activity-dependent manner, which enables D 4 receptors to serve as a homeostatic synaptic factor to stabilize the excitability of cortical circuits. Because dysfunction of glutamatergic transmission is the core feature and fundamental pathology of mental disorders (43), our results provide a potential framework for understanding the link of aberrant D 4 functions to ADHD (7) (8) (9) (10) (11) and schizophrenia (14) .
Materials and Methods
AMPAR-EPSC was recorded in PFC neurons from young SD rats as previously described (34) . Standard immunocytochemical and biochemical approaches were used to measure synaptic and surface AMPARs (24, 31, 34) . For details, see SI Materials and Methods.
